Generate Biomedicines, Inc.
GENBNasdaqCIK 2100782HealthcareFiscal year ends Dec 31
Reports and events: 9 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2619:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-365556 |
| 2026-08-0606:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-336437 |
| 2026-08-0606:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336462 |
| 2026-05-0706:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-210059 |
| 2026-05-0706:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-209899 |
| 2026-03-0217:22 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-085780 |
| 2026-02-2306:37 ET | S-1/A | Registration statement, amended | 0001193125-26-062362 |
| 2026-02-1317:15 ET | S-1/A | Registration statement, amended | 0001193125-26-051761 |
| 2026-02-0417:02 ET | S-1 | Registration statement | 0001193125-26-037799 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:13 ET. Listed shows no prices and gives no investment advice.